ES2690199T3 - Uso de células madre para reducir la extravasación de leucocitos - Google Patents

Uso de células madre para reducir la extravasación de leucocitos Download PDF

Info

Publication number: ES2690199T3
Authority: ES; Spain
Prior art keywords: cells; cell; reduce; stem cells; somatic
Prior art date: 2009-07-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES10802822.6T

Other languages

English (en)

Spanish (es)

Inventor

Wouter Van't Hof

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

ABT Holding Co

Original Assignee

ABT Holding Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-07-21

Filing date

2010-07-21

Publication date

2018-11-19

2010-07-21 Application filed by ABT Holding Co filed Critical ABT Holding Co

2018-11-19 Application granted granted Critical

2018-11-19 Publication of ES2690199T3 publication Critical patent/ES2690199T3/es

Status Active legal-status Critical Current

2030-07-21 Anticipated expiration legal-status Critical

Links

210000000265 leukocyte Anatomy 0.000 title abstract description 7
206010015866 Extravasation Diseases 0.000 title abstract description 3
230000036251 extravasation Effects 0.000 title abstract description 3
210000000130 stem cell Anatomy 0.000 title description 9
210000004027 cell Anatomy 0.000 abstract description 68
230000014509 gene expression Effects 0.000 abstract description 7
206010061218 Inflammation Diseases 0.000 abstract description 2
210000004602 germ cell Anatomy 0.000 abstract description 2
210000001654 germ layer Anatomy 0.000 abstract description 2
230000004054 inflammatory process Effects 0.000 abstract description 2
101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 abstract 1
101710150336 Protein Rex Proteins 0.000 abstract 1
108010017842 Telomerase Proteins 0.000 abstract 1
210000002889 endothelial cell Anatomy 0.000 abstract 1
210000003989 endothelium vascular Anatomy 0.000 abstract 1
230000023404 leukocyte cell-cell adhesion Effects 0.000 abstract 1
210000001082 somatic cell Anatomy 0.000 description 9
238000000034 method Methods 0.000 description 8
210000001185 bone marrow Anatomy 0.000 description 7
230000036515 potency Effects 0.000 description 6
108090000623 proteins and genes Proteins 0.000 description 6
230000004927 fusion Effects 0.000 description 5
230000008672 reprogramming Effects 0.000 description 5
230000000392 somatic effect Effects 0.000 description 5
238000012360 testing method Methods 0.000 description 5
238000002955 isolation Methods 0.000 description 4
239000002609 medium Substances 0.000 description 4
238000010449 nuclear transplantation Methods 0.000 description 4
210000004940 nucleus Anatomy 0.000 description 4
210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 4
238000010374 somatic cell nuclear transfer Methods 0.000 description 4
241001465754 Metazoa Species 0.000 description 3
230000001464 adherent effect Effects 0.000 description 3
230000000694 effects Effects 0.000 description 3
210000002308 embryonic cell Anatomy 0.000 description 3
210000004700 fetal blood Anatomy 0.000 description 3
210000004185 liver Anatomy 0.000 description 3
238000010208 microarray analysis Methods 0.000 description 3
239000000203 mixture Substances 0.000 description 3
210000005087 mononuclear cell Anatomy 0.000 description 3
210000003205 muscle Anatomy 0.000 description 3
238000000926 separation method Methods 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
102100032752 C-reactive protein Human genes 0.000 description 2
101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 description 2
241001529936 Murinae Species 0.000 description 2
102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
230000004913 activation Effects 0.000 description 2
210000004504 adult stem cell Anatomy 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
210000000988 bone and bone Anatomy 0.000 description 2
210000004556 brain Anatomy 0.000 description 2
210000000845 cartilage Anatomy 0.000 description 2
238000004113 cell culture Methods 0.000 description 2
230000007012 clinical effect Effects 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
210000001671 embryonic stem cell Anatomy 0.000 description 2
230000001973 epigenetic effect Effects 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
238000002474 experimental method Methods 0.000 description 2
239000003102 growth factor Substances 0.000 description 2
210000000287 oocyte Anatomy 0.000 description 2
210000002826 placenta Anatomy 0.000 description 2
230000011664 signaling Effects 0.000 description 2
210000003491 skin Anatomy 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000012546 transfer Methods 0.000 description 2
102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 1
108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 1
108010074051 C-Reactive Protein Proteins 0.000 description 1
201000009030 Carcinoma Diseases 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
230000004543 DNA replication Effects 0.000 description 1
102000009024 Epidermal Growth Factor Human genes 0.000 description 1
101800003838 Epidermal growth factor Proteins 0.000 description 1
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
102100037362 Fibronectin Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 1
108010013709 Leukocyte Common Antigens Proteins 0.000 description 1
102000017095 Leukocyte Common Antigens Human genes 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
238000002123 RNA extraction Methods 0.000 description 1
102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 1
210000001766 X chromosome Anatomy 0.000 description 1
230000010398 acute inflammatory response Effects 0.000 description 1
210000001789 adipocyte Anatomy 0.000 description 1
210000000577 adipose tissue Anatomy 0.000 description 1
210000004381 amniotic fluid Anatomy 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
239000000090 biomarker Substances 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000002798 bone marrow cell Anatomy 0.000 description 1
210000004271 bone marrow stromal cell Anatomy 0.000 description 1
229940112869 bone morphogenetic protein Drugs 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
230000008859 change Effects 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000010367 cloning Methods 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000000959 cryoprotective effect Effects 0.000 description 1
238000012364 cultivation method Methods 0.000 description 1
230000000779 depleting effect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000004069 differentiation Effects 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000013020 embryo development Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
229940116977 epidermal growth factor Drugs 0.000 description 1
210000002514 epidermal stem cell Anatomy 0.000 description 1
230000007608 epigenetic mechanism Effects 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000004754 hybrid cell Anatomy 0.000 description 1
230000036512 infertility Effects 0.000 description 1
210000004969 inflammatory cell Anatomy 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000007443 liposuction Methods 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000007885 magnetic separation Methods 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
MIKKOBKEXMRYFQ-WZTVWXICSA-N meglumine amidotrizoate Chemical compound C[NH2+]C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I MIKKOBKEXMRYFQ-WZTVWXICSA-N 0.000 description 1
230000000877 morphologic effect Effects 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
210000003924 normoblast Anatomy 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
238000010373 organism cloning Methods 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
230000002093 peripheral effect Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000007420 reactivation Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000008943 replicative senescence Effects 0.000 description 1
241000894007 species Species 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
210000002536 stromal cell Anatomy 0.000 description 1
239000000758 substrate Substances 0.000 description 1
108091035539 telomere Proteins 0.000 description 1
102000055501 telomere Human genes 0.000 description 1
210000003411 telomere Anatomy 0.000 description 1
210000002435 tendon Anatomy 0.000 description 1
238000010257 thawing Methods 0.000 description 1
238000010361 transduction Methods 0.000 description 1
230000026683 transduction Effects 0.000 description 1
210000003954 umbilical cord Anatomy 0.000 description 1
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/03—Coculture with; Conditioned medium produced by non-embryonic pluripotent stem cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/11—Coculture with; Conditioned medium produced by blood or immune system cells

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Immunology (AREA)
Developmental Biology & Embryology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
General Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Physics & Mathematics (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Virology (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Tropical Medicine & Parasitology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Gynecology & Obstetrics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)

ES10802822.6T 2009-07-21 2010-07-21 Uso de células madre para reducir la extravasación de leucocitos Active ES2690199T3 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US22731109P	2009-07-21	2009-07-21
US227311P		2009-07-21
PCT/US2010/042690 WO2011011477A1 (en)	2009-07-21	2010-07-21	Use of stem cells to reduce leukocyte extravasation

Publications (1)

Publication Number	Publication Date
ES2690199T3 true ES2690199T3 (es)	2018-11-19

Family

ID=43497498

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES10802822.6T Active ES2690199T3 (es)	2009-07-21	2010-07-21	Uso de células madre para reducir la extravasación de leucocitos

Country Status (9)

Country	Link
US (2)	US20110020292A1 (da)
EP (1)	EP2456860B1 (da)
AU (1)	AU2010276264B2 (da)
CA (1)	CA2768573C (da)
DK (1)	DK2456860T3 (da)
ES (1)	ES2690199T3 (da)
IL (1)	IL217643B (da)
SG (3)	SG10201913618WA (da)
WO (1)	WO2011011477A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7015037B1 (en)	1999-08-05	2006-03-21	Regents Of The University Of Minnesota	Multiponent adult stem cells and methods for isolation
AU2009205886B2 (en)	2008-01-18	2015-08-27	Katholieke Universiteit Leuven	Stem cell aggregates and methods for making and using
SG185526A1 (en)	2010-05-12	2012-12-28	Abt Holding Co	Modulation of splenocytes in cell therapy
IL289870B2 (en)	2013-04-12	2023-03-01	Lafrancesca Saverio	Improving organs for transplantation
NZ745530A (en)	2016-01-21	2023-03-31	Abt Holding Co	Stem cells for wound healing
KR102396838B1 (ko) *	2016-05-20	2022-05-11	로버트 색스테인	E-셀렉틴 리간드의 당조작
EP4138868A1 (en) *	2020-04-23	2023-03-01	ABT Holding Company	Treatment of virus-induced acute respiratory distress syndrome
JP2024542455A (ja) *	2021-11-15	2024-11-15	ウェイク・フォレスト・ユニヴァーシティ・ヘルス・サイエンシズ	インビトロで活性化されたエフェクター細胞での組織再生

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4657866A (en)	1982-12-21	1987-04-14	Sudhir Kumar	Serum-free, synthetic, completely chemically defined tissue culture media
JPH04500909A (ja)	1988-09-21	1992-02-20	アニマル　バイオテクノロジー　ケンブリッジ　リミティド	家畜からの多能性胚細胞系の誘導
US7037721B1 (en)	1990-01-29	2006-05-02	Hy-Gene Biomedical, Inc.	Protein-free defined media for the growth of normal human keratinocytes
US5837539A (en)	1990-11-16	1998-11-17	Osiris Therapeutics, Inc.	Monoclonal antibodies for human mesenchymal stem cells
US5811094A (en)	1990-11-16	1998-09-22	Osiris Therapeutics, Inc.	Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) *	1990-11-16	1996-01-23	Osiris Therapeutics, Inc.	Human mesenchymal stem cells
GB2254289B (en)	1991-04-05	1995-03-22	Gerber Garment Technology Inc	Readily transferrable adherent tape and methods of use and making
AU2882992A (en)	1991-11-06	1993-06-07	Arthur A. Axelrad	Cell culture medium
US5340740A (en)	1992-05-15	1994-08-23	North Carolina State University	Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
AU4543193A (en)	1992-06-22	1994-01-24	Henry E. Young	Scar inhibitory factor and use thereof
US5453357A (en)	1992-10-08	1995-09-26	Vanderbilt University	Pluripotential embryonic stem cells and methods of making same
US7153684B1 (en)	1992-10-08	2006-12-26	Vanderbilt University	Pluripotential embryonic stem cells and methods of making same
US5766951A (en)	1992-11-12	1998-06-16	Quality Biological, Inc.	Serum-free medium supporting growth and proliferation of normal bone marrow cells
US6037174A (en)	1993-08-23	2000-03-14	Nexell Therapeutics, Inc.	Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5409813A (en)	1993-09-30	1995-04-25	Systemix, Inc.	Method for mammalian cell separation from a mixture of cell populations
US6432711B1 (en)	1993-11-03	2002-08-13	Diacrin, Inc.	Embryonic stem cells capable of differentiating into desired cell lines
FR2726003B1 (fr)	1994-10-21	2002-10-18	Agronomique Inst Nat Rech	Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
US5874301A (en)	1994-11-21	1999-02-23	National Jewish Center For Immunology And Respiratory Medicine	Embryonic cell populations and methods to isolate such populations
US5914268A (en)	1994-11-21	1999-06-22	National Jewish Center For Immunology & Respiratory Medicine	Embryonic cell populations and methods to isolate such populations
US5843780A (en)	1995-01-20	1998-12-01	Wisconsin Alumni Research Foundation	Primate embryonic stem cells
US5736396A (en)	1995-01-24	1998-04-07	Case Western Reserve University	Lineage-directed induction of human mesenchymal stem cell differentiation
GB9502022D0 (en) *	1995-02-02	1995-03-22	Abuljadayel Ilham M S	A method for preparing lymphohaematopoietic progenitor cells
US5906934A (en) *	1995-03-14	1999-05-25	Morphogen Pharmaceuticals, Inc.	Mesenchymal stem cells for cartilage repair
US6653134B2 (en) *	1995-03-28	2003-11-25	Cp Hahnemann University	Isolated stromal cells for use in the treatment of diseases of the central nervous system
US5837670A (en)	1995-04-18	1998-11-17	Hartshorn; Richard Timothy	Detergent compositions having suds suppressing properties
US5908782A (en)	1995-06-05	1999-06-01	Osiris Therapeutics, Inc.	Chemically defined medium for human mesenchymal stem cells
WO1997032889A1 (en) *	1996-03-08	1997-09-12	The Regents Of The University Of Michigan	MURINE α(1,3)FUCOSYLTRANSFERASE Fuc-TVII, DNA ENCODING THE SAME, METHOD FOR PREPARING THE SAME, ANTIBODIES RECOGNIZING THE SAME, IMMUNOASSAYS FOR DETECTING THE SAME, PLASMIDS CONTAINING SUCH DNA, AND CELLS CONTAINING SUCH A PLASMID
US6190910B1 (en)	1996-05-21	2001-02-20	The Institute Of Physical And Chemical Research	Mouse embryonic stem cell lines
US5753506A (en)	1996-05-23	1998-05-19	Cns Stem Cell Technology, Inc.	Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
US5827740A (en)	1996-07-30	1998-10-27	Osiris Therapeutics, Inc.	Adipogenic differentiation of human mesenchymal stem cells
US5945337A (en)	1996-10-18	1999-08-31	Quality Biological, Inc.	Method for culturing CD34+ cells in a serum-free medium
US6361996B1 (en)	1997-05-07	2002-03-26	University Of Utah Research Foundation	Neuroepithelial stem cells and glial-restricted intermediate precursors
WO1998059035A2 (en)	1997-06-25	1998-12-30	The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health	Serum-free cell growth medium
JP4371179B2 (ja)	1997-07-04	2009-11-25	ユニバーシティーオブユタリサーチファンデーション	系列限定ニューロン前駆体
US5968829A (en)	1997-09-05	1999-10-19	Cytotherapeutics, Inc.	Human CNS neural stem cells
CA2348687A1 (en)	1998-11-09	2000-05-18	Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate	Serum free medium for chondrocyte-like cells
US6875607B1 (en)	1998-11-09	2005-04-05	Es Cell International Pte Ltd	Embryonic stem cells
US20050153442A1 (en)	1999-03-10	2005-07-14	Adam Katz	Adipose-derived stem cells and lattices
US6777231B1 (en) *	1999-03-10	2004-08-17	The Regents Of The University Of California	Adipose-derived stem cells and lattices
US20050169896A1 (en) *	1999-05-14	2005-08-04	Henry Ford Health System	Bone marrow transplantation for treatment of stroke
US8147824B2 (en) *	1999-08-05	2012-04-03	Athersys, Inc.	Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
WO2002064748A2 (en) *	2001-02-14	2002-08-22	Furcht Leo T	Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
WO2001011011A2 (en) *	1999-08-05	2001-02-15	Mcl Llc	Multipotent adult stem cells and methods for isolation
US7015037B1 (en)	1999-08-05	2006-03-21	Regents Of The University Of Minnesota	Multiponent adult stem cells and methods for isolation
US20030161817A1 (en) *	2001-03-28	2003-08-28	Young Henry E.	Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
NZ518601A (en) *	1999-09-24	2004-10-29	Morphogen Pharmaceuticals Inc	Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2001021767A2 (en) *	1999-09-24	2001-03-29	Morphogen Pharmaceuticals, Inc.	Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
CA2392615A1 (en) *	1999-12-06	2001-06-07	The General Hospital Corporation	Pancreatic stem cells and their use in transplantation
EP1261694B1 (en) *	2000-02-26	2008-01-16	Artecel, Inc.	Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
US7582292B2 (en) *	2000-02-26	2009-09-01	Artecel, Inc.	Adipose tissue derived stromal cells for the treatment of neurological disorders
EP2298867A3 (en)	2000-06-20	2013-01-16	ES Cell International Pte Ltd.	Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists
US20020061587A1 (en) *	2000-07-31	2002-05-23	Piero Anversa	Methods and compositions for the repair and/or regeneration of damaged myocardium
AU2001296705A1 (en) *	2000-10-06	2002-04-15	The Regents Of The University Of California	Blocking inflammation by inhibiting sialylation
US7560280B2 (en) *	2000-11-03	2009-07-14	Kourion Therapeutics Gmbh	Human cord blood derived unrestricted somatic stem cells (USSC)
US7311905B2 (en) *	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
DK1349918T3 (da) *	2000-12-06	2014-11-10	Anthrogenesis Corp	Fremgangsmåde til indsamling af stamceller fra moderkagen
EP2316919B1 (en) *	2001-02-14	2015-10-07	Anthrogenesis Corporation	Post-partum mammalian placenta, its use and placental stem cells therefrom
US7056738B2 (en) *	2001-03-23	2006-06-06	Tulane University	Early stage multipotential stem cells in colonies of bone marrow stromal cells
KR100449141B1 (ko) *	2001-04-19	2004-09-21	(주)라이프코드	간엽 간세포를 신경세포로 분화시키는 방법
US20030003090A1 (en) *	2001-05-31	2003-01-02	Prockop Darwin J.	Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
EP1421181A1 (en)	2001-08-23	2004-05-26	Reliance Life Sciences Pvt., Ltd.	ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
US9969980B2 (en)	2001-09-21	2018-05-15	Garnet Biotherapeutics	Cell populations which co-express CD49c and CD90
US6703279B2 (en)	2002-01-04	2004-03-09	Promos Technologies, Inc.	Semiconductor device having contact of Si-Ge combined with cobalt silicide
EP1478734A4 (en)	2002-01-25	2006-04-05	Genzyme Corp	NON-SERUM MEDIUM FOR CHONDROCYTES AND METHODS OF USE THEREOF
US7145057B2 (en)	2002-02-01	2006-12-05	Origen Therapeutics, Inc.	Chimeric bird from embryonic stem cells
AU2003230695A1 (en)	2002-03-20	2003-10-08	Sara Griffin	Sports training device
GB0221481D0 (en)	2002-09-16	2002-10-23	Richards John M	Grip for hand held instruments
US7785601B2 (en) *	2002-12-31	2010-08-31	Sygnis Bioscience Gmbh & Co. Kg	Methods of treating neurological conditions with hematopoietic growth factors
US20040235165A1 (en) *	2003-05-19	2004-11-25	Darwin Prockop	In vitro differentiation of adult stem cells
WO2005041944A2 (en) *	2003-06-27	2005-05-12	Schepens Eye Research Institute	Methods and compositions for promoting axon regeneration and cell replacement therapy
EP2133362B1 (en) *	2003-07-25	2012-04-18	Amgen, Inc	Methods relating to LDCAM and CRTAM
AU2004269409A1 (en) *	2003-08-29	2005-03-10	Regents Of The University Of Minnesota	Kidney derived stem cells and methods for their isolation, differentiation and use
WO2005025502A2 (en) *	2003-09-08	2005-03-24	Yeda Research And Development Co. Ltd.	A method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration
US7622108B2 (en) *	2004-04-23	2009-11-24	Bioe, Inc.	Multi-lineage progenitor cells
CN104027359A (zh) *	2006-01-23	2014-09-10	阿特西斯公司	无附加的免疫抑制治疗的mapc治疗法
US20100287638A1 (en) *	2007-10-01	2010-11-11	The Hospital For Sick Children	Neural tumor stem cells and methods of use thereof
US20090130092A1 (en) *	2007-10-30	2009-05-21	Pinsky David J	Nucleotide phosphate dissipation as a treatment for vascular disorders

2010
- 2010-07-21 WO PCT/US2010/042690 patent/WO2011011477A1/en not_active Ceased
- 2010-07-21 SG SG10201913618WA patent/SG10201913618WA/en unknown
- 2010-07-21 US US12/840,420 patent/US20110020292A1/en not_active Abandoned
- 2010-07-21 EP EP10802822.6A patent/EP2456860B1/en active Active
- 2010-07-21 DK DK10802822.6T patent/DK2456860T3/da active
- 2010-07-21 AU AU2010276264A patent/AU2010276264B2/en not_active Ceased
- 2010-07-21 SG SG2012004164A patent/SG178065A1/en unknown
- 2010-07-21 CA CA2768573A patent/CA2768573C/en active Active
- 2010-07-21 SG SG10201404281YA patent/SG10201404281YA/en unknown
- 2010-07-21 ES ES10802822.6T patent/ES2690199T3/es active Active
2012
- 2012-01-19 IL IL217643A patent/IL217643B/en active IP Right Grant
2013
- 2013-11-01 US US14/070,075 patent/US20140134137A1/en active Pending

Also Published As

Publication number	Publication date
DK2456860T3 (da)	2019-01-07
WO2011011477A1 (en)	2011-01-27
SG10201913618WA (en)	2020-03-30
SG10201404281YA (en)	2014-09-26
IL217643B (en)	2018-03-29
EP2456860A1 (en)	2012-05-30
EP2456860A4 (en)	2013-08-28
AU2010276264A1 (en)	2012-03-01
CA2768573C (en)	2020-09-15
EP2456860B1 (en)	2018-09-05
CA2768573A1 (en)	2011-01-27
AU2010276264B2 (en)	2013-09-19
US20140134137A1 (en)	2014-05-15
SG178065A1 (en)	2012-03-29
US20110020292A1 (en)	2011-01-27

Publication	Publication Date	Title
ES2690199T3 (es)	2018-11-19	Uso de células madre para reducir la extravasación de leucocitos
Seshareddy et al.	2008	Method to isolate mesenchymal‐like cells from Wharton's Jelly of umbilical cord
Smith	2003	Hematopoietic stem cells and hematopoiesis
KR101582483B1 (ko)	2016-01-06	심근 세포의 세포괴의 제조 방법 및 상기 심근 세포괴의 용도
US9617515B2 (en)	2017-04-11	Non-embryonic totipotent blastomere-like stem cells and methods therefor
AU2018223029A1 (en)	2018-09-20	Expansion of stem cells in hollow fiber bioreactors
Mehrabani et al.	2016	Growth kinetics, characterization, and plasticity of human menstrual blood stem cells
Zuba-Surma et al.	2009	Very small embryonic-like stem cells in adult tissues—Potential implications for aging
JP7025077B2 (ja)	2022-02-24	ヒト褐色脂肪由来幹細胞およびその使用
TW201441369A (zh)	2014-11-01	多向分化壓力耐受（ｍｕｓｅ）細胞分離及擴增
JP2021058218A (ja)	2021-04-15	血管形成の調節
Sahoo et al.	2017	Isolation, culture, characterization, and osteogenic differentiation of canine endometrial mesenchymal stem cell
Gheller et al.	2019	Isolation, culture, characterization, and differentiation of human muscle progenitor cells from the skeletal muscle biopsy procedure
US11920180B2 (en)	2024-03-05	Method for inducing differentiation of pluripotent stem cells in vitro
JP2009055866A (ja)	2009-03-19	滑膜組織由来の幹細胞および細胞株ならびにその濃縮培養方法
AU2019345595A1 (en)	2021-04-15	Mammal cell preserving solution containing acarbose or stachyose
JP2020500023A (ja)	2020-01-09	マイクロ流体システムおよびその使用の方法
KR100851040B1 (ko)	2008-08-12	췌장 베타세포로의 분화능을 가지는 성체 줄기세포
Gekas et al.	2008	Isolation and visualization of mouse placental hematopoietic stem cells
EP2149602B1 (en)	2014-12-17	Method for concentration of side population cell fraction
Yamaoka et al.	2011	Cell rolling column in purification and differentiation analysis of stem cells
KR20250154508A (ko)	2025-10-28	미세유기구에서의 세포 표지 및 주석
Seshareddy	2008	Human Wharton’s jelly cells-isolation and characterization in different growth conditions
CN113136411A (zh)	2021-07-20	使用人体干细胞的评估方法、药物评估方法及检测试剂盒
Rodríguez-Hernández et al.	2014	International Journal of Current Research and Academic Review